253 related articles for article (PubMed ID: 17130626)
1. Challenging the epidemiologic evidence on passive smoking: tactics of tobacco industry expert witnesses.
Francis JA; Shea AK; Samet JM
Tob Control; 2006 Dec; 15 Suppl 4(Suppl 4):iv68-76. PubMed ID: 17130626
[TBL] [Abstract][Full Text] [Related]
2. The Tobacco Deposition and Trial Testimony Archive (DATTA) project: origins, aims, and methods.
Davis RM; Douglas CE; Beasley JK
Tob Control; 2006 Dec; 15 Suppl 4(Suppl 4):iv4-8. PubMed ID: 17130623
[TBL] [Abstract][Full Text] [Related]
3. The role of tobacco advertising and promotion: themes employed in litigation by tobacco industry witnesses.
Goldberg ME; Davis RM; O'Keefe AM
Tob Control; 2006 Dec; 15 Suppl 4(Suppl 4):iv54-67. PubMed ID: 17130625
[TBL] [Abstract][Full Text] [Related]
4. Changing conclusions on secondhand smoke in a sudden infant death syndrome review funded by the tobacco industry.
Tong EK; England L; Glantz SA
Pediatrics; 2005 Mar; 115(3):e356-66. PubMed ID: 15741361
[TBL] [Abstract][Full Text] [Related]
5. Testimony by otolaryngologists in defense of tobacco companies 2009-2014.
Jackler RK
Laryngoscope; 2015 Dec; 125(12):2722-9. PubMed ID: 26186270
[TBL] [Abstract][Full Text] [Related]
6. Tobacco manufacturers' defence against plaintiffs' claims of cancer causation: throwing mud at the wall and hoping some of it will stick.
Milberger S; Davis RM; Douglas CE; Beasley JK; Burns D; Houston T; Shopland D
Tob Control; 2006 Dec; 15 Suppl 4(Suppl 4):iv17-26. PubMed ID: 17130620
[TBL] [Abstract][Full Text] [Related]
7. Perceptions of industry responsibility and tobacco control policy by US tobacco company executives in trial testimony.
Chaiton M; Ferrence R; LeGresley E
Tob Control; 2006 Dec; 15 Suppl 4(Suppl 4):iv98-106. PubMed ID: 17130631
[TBL] [Abstract][Full Text] [Related]
8. The impact of strategic funding by the tobacco industry of medical expert witnesses appearing for the defence in the Aho Finnish product liability case.
Hiilamo HT
Addiction; 2007 Jun; 102(6):979-88. PubMed ID: 17523993
[TBL] [Abstract][Full Text] [Related]
9. Ethical implications of physician involvement in lawsuits on behalf of the tobacco industry.
Alderman J
J Law Med Ethics; 2007; 35(4):692-8, 513. PubMed ID: 18076519
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of the third wave of tobacco litigation in the United States, 1994-2005.
Douglas CE; Davis RM; Beasley JK
Tob Control; 2006 Dec; 15 Suppl 4(Suppl 4):iv9-16. PubMed ID: 17130629
[TBL] [Abstract][Full Text] [Related]
11. Scottish court dismisses a historic smoker's suit.
Friedman L; Daynard R
Tob Control; 2007 Oct; 16(5):e4. PubMed ID: 17897973
[TBL] [Abstract][Full Text] [Related]
12. Historians' testimony on "common knowledge" of the risks of tobacco use: a review and analysis of experts testifying on behalf of cigarette manufacturers in civil litigation.
Kyriakoudes LM
Tob Control; 2006 Dec; 15 Suppl 4(Suppl 4):iv107-16. PubMed ID: 17130618
[TBL] [Abstract][Full Text] [Related]
13. How tobacco-friendly science escapes scrutiny in the courtroom.
Friedman LC; Daynard RA; Banthin CN
Am J Public Health; 2005; 95 Suppl 1():S16-20. PubMed ID: 16030332
[TBL] [Abstract][Full Text] [Related]
14. Potential reduced exposure products (PREPs) in industry trial testimony.
Wayne GF
Tob Control; 2006 Dec; 15 Suppl 4(Suppl 4):iv90-7. PubMed ID: 17130630
[TBL] [Abstract][Full Text] [Related]
15. Risk of lung cancer from environmental exposures to tobacco smoke.
Dockery DW; Trichopoulos D
Cancer Causes Control; 1997 May; 8(3):333-45. PubMed ID: 9498897
[TBL] [Abstract][Full Text] [Related]
16. The tobacco industry and secondhand smoke: lessons from Central and South America.
Barnoya J; Glantz SA
Ethn Dis; 2003; 13(2 Suppl 2):S88-90. PubMed ID: 13677420
[TBL] [Abstract][Full Text] [Related]
17. "Stay away from them until you're old enough to make a decision": tobacco company testimony about youth smoking initiation.
Wakefield M; McLeod K; Perry CL
Tob Control; 2006 Dec; 15 Suppl 4(Suppl 4):iv44-53. PubMed ID: 17130624
[TBL] [Abstract][Full Text] [Related]
18. Tobacco industry efforts undermining evidence linking secondhand smoke with cardiovascular disease.
Tong EK; Glantz SA
Circulation; 2007 Oct; 116(16):1845-54. PubMed ID: 17938301
[TBL] [Abstract][Full Text] [Related]
19. "Conclusions about exposure to ETS and health that will be unhelpful to us": how the tobacco industry attempted to delay and discredit the 1997 Australian National Health and Medical Research Council report on passive smoking.
Trotter L; Chapman S
Tob Control; 2003 Dec; 12 Suppl 3(Suppl 3):iii102-6. PubMed ID: 14645955
[TBL] [Abstract][Full Text] [Related]
20. Development of a model of the tobacco industry's interference with tobacco control programmes.
Trochim WM; Stillman FA; Clark PI; Schmitt CL
Tob Control; 2003 Jun; 12(2):140-7. PubMed ID: 12773723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
